Should older head and neck patients be treated differently?

Area of Science:

• Oncology
• Geriatric Medicine
• Head and Neck Surgery

Background:

• Increasing life expectancy leads to a rise in elderly patients diagnosed with upper aerodigestive tract tumors.
• Head and neck squamous cell carcinoma (HNSCC) is a significant health concern in the aging population.

Purpose of the Study:

• To evaluate the suitability of aggressive curative treatment for elderly patients (over 70) with HNSCC.
• To analyze the impact of comorbidities on treatment outcomes in this demographic.

Main Methods:

• Retrospective review of 44 patients over 70 with HNSCC treated between 2005-2007.
• Assessment of demographics, comorbidities, treatment modalities (radiation, chemoradiotherapy, surgery), and 36-month follow-up data including morbidity and mortality.

Main Results:

• The study included 44 patients (32 males, 12 females) with a median age of 77 years, most having at least one comorbidity.
• Various treatment strategies were employed, including radiation alone, chemoradiotherapy, and surgery with adjuvant therapy.
• At 36 months, 32 patients were alive, with deaths attributed to recurrence, treatment complications, and other medical events.

Conclusions:

• Age alone should not be a barrier to aggressive curative treatment for medically eligible HNSCC patients.
• Individualized treatment planning, considering patient comorbidities, is crucial for optimizing outcomes in elderly HNSCC patients.